Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Charles Daley to Tuberculosis, Multidrug-Resistant

This is a "connection" page, showing publications Charles Daley has written about Tuberculosis, Multidrug-Resistant.

 
Connection Strength
 
 
 
3.779
 
  1. Daley CL, Caminero JA. Management of Multidrug-Resistant Tuberculosis. Semin Respir Crit Care Med. 2018 Jun; 39(3):310-324.
    View in: PubMed
    Score: 0.637
  2. Daley CL. Global scale-up of the programmatic management of multidrug-resistant tuberculosis. Indian J Tuberc. 2014 Apr; 61(2):108-15.
    View in: PubMed
    Score: 0.471
  3. Daley CL. Mycobacterial infections--update from the "International Pulmonary Update". Indian J Tuberc. 2014 Jan; 61(1):89.
    View in: PubMed
    Score: 0.463
  4. Daley CL, Caminero JA. Management of multidrug resistant tuberculosis. Semin Respir Crit Care Med. 2013 Feb; 34(1):44-59.
    View in: PubMed
    Score: 0.438
  5. Chang KC, Leung CC, Daley CL. Linezolid for multidrug-resistant tuberculosis - authors' reply. Lancet Infect Dis. 2013 Jan; 13(1):16-7.
    View in: PubMed
    Score: 0.432
  6. Chang KC, Leung CC, Daley CL. Linezolid for multidrug-resistant tuberculosis. Lancet Infect Dis. 2012 Jul; 12(7):502-3.
    View in: PubMed
    Score: 0.418
  7. Daley CL. Transmission of multidrug-resistant tuberculosis: limited by man or nature? Am J Respir Crit Care Med. 2002 Mar 15; 165(6):742-3.
    View in: PubMed
    Score: 0.205
  8. Nahid P, Mase SR, Migliori GB, Sotgiu G, Bothamley GH, Brozek JL, Cattamanchi A, Cegielski JP, Chen L, Daley CL, Dalton TL, Duarte R, Fregonese F, Horsburgh CR, Ahmad Khan F, Kheir F, Lan Z, Lardizabal A, Lauzardo M, Mangan JM, Marks SM, McKenna L, Menzies D, Mitnick CD, Nilsen DM, Parvez F, Peloquin CA, Raftery A, Schaaf HS, Shah NS, Starke JR, Wilson JW, Wortham JM, Chorba T, Seaworth B. Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline. Am J Respir Crit Care Med. 2019 11 15; 200(10):e93-e142.
    View in: PubMed
    Score: 0.174
  9. Daley CL. The Global Fight Against Tuberculosis. Thorac Surg Clin. 2019 Feb; 29(1):19-25.
    View in: PubMed
    Score: 0.165
  10. Mitnick CD, Rodriguez CA, Hatton ML, Brigden G, Cobelens F, Grobusch MP, Horsburgh R, Lange C, Lienhardt C, Oren E, Podewils LJ, Seaworth B, van den Hof S, Daley CL, Gebhard AC, Wares F. Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda. PLoS One. 2016; 11(5):e0155968.
    View in: PubMed
    Score: 0.137
  11. Mase SR, Jereb JA, Gonzalez D, Martin F, Daley CL, Fred D, Loeffler AM, Menon LR, Bamrah Morris S, Brostrom R, Chorba T, Peloquin CA. Pharmacokinetics and Dosing of Levofloxacin in Children Treated for Active or Latent Multidrug-resistant Tuberculosis, Federated States of Micronesia and Republic of the Marshall Islands. Pediatr Infect Dis J. 2016 Apr; 35(4):414-21.
    View in: PubMed
    Score: 0.135
  12. Walter ND, Strong M, Belknap R, Ordway DJ, Daley CL, Chan ED. Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis. Respirology. 2012 Jul; 17(5):772-91.
    View in: PubMed
    Score: 0.104
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)